Trevi Therapeutics stockTRVI
Trevi Therapeutics trades at $12.81, 36.6% below its 52-week high (Jul 17, 2026). The price is below its 50- and 200-day averages, a downtrend. +2.3% year to date, +20.4% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 9, 2026.
Ratings, candles, signals and the screener for TRVI — after you log in
Open the terminalFrequently asked questions about Trevi Therapeutics
What is the Trevi Therapeutics stock price?
At the close on Nov 5, 2026: $12.81 (−8.40% on the day). 52-week high: $20.22 on Jul 17, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Trevi Therapeutics report earnings?
The next quarterly report is on Nov 9, 2026. Last quarter, earnings per share changed −22% year over year, revenue 0%.
Does Trevi Therapeutics pay dividends?
No, Trevi Therapeutics does not pay dividends.
Where does Trevi Therapeutics trade and how to buy it?
Ticker TRVI, exchange Nasdaq, listed since 2019. You can buy it through a broker with access to US exchanges.
Should I buy Trevi Therapeutics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for TRVI are in the terminal after you log in.